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Abstract
The pneumococcus produces a polysaccharide capsule, encoded by the cps locus, that provides protection against phagocytosis and 
determines serotype. Nearly 100 serotypes have been identified with new serotypes still being discovered, especially in previously 
understudied regions. Here we present an analysis of the cps loci of more than 18  000 genomes from the Global Pneumococcal 
Sequencing (GPS) project with the aim of identifying novel cps loci with the potential to produce previously unrecognized capsule 
structures. Serotypes were assigned using whole genome sequence data and 66 of the approximately 100 known serotypes were 
included in the final dataset. Closer examination of each serotype’s sequences identified nine putative novel cps loci (9X, 11X, 16X, 
18X1, 18X2, 18X3, 29X, 33X and 36X) found in ~2.6  % of the genomes. The large number and global distribution of GPS genomes 
provided an unprecedented opportunity to identify novel cps loci and consider their phylogenetic and geographical distribution. Nine 
putative novel cps loci were identified and examples of each will undergo subsequent structural and immunological analysis.
DATA SummARy
1. Supplementary files 1 and 2 (available in the online version 
of this article).
2. Raw sequencing data for all study genomes have been 
deposited in the European Nucleotide Archive (ENA). Acces-
sion numbers are detailed in Table S1.
3. Nucleotide sequences for each putative novel cps locus 
have been deposited in GenBank (Accession numbers 
MK606429–MK606437)
InTRoDuCTIon
Streptococcus pneumoniae (the pneumococcus) is a Gram-
positive human commensal that is also responsible for a 
significant global disease burden, with pneumococcal-related 
diseases such as pneumonia and meningitis responsible for 
an estimated 300 000–500 000 deaths in children <5 years 
of age each year in the pre-vaccine era [1]. The pneumo-
coccus produces an extracellular polysaccharide capsule that 
provides protection against phagocytosis and is the primary 
pneumococcal virulence factor [2–4]. With the exception 
of synthase-dependent serotypes 3 and 37, all serotypes use 
the Wzy-dependent system to produce the polysaccharide 
capsule [5]. The capsule is encoded by the CPS synthesis (cps) 
locus situated between the dexB and aliA genes (the serotype 
37 capsule is produced by the tts, located outside the cps locus) 
and approximately 100 capsular types (serotypes) have been 
identified, with novel serotypes still being discovered [6–8]. 
A comparative analysis of 90 cps loci showed that there is 
an extensive repertoire of ~2000 coding sequences that can 
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be divided into three functional groups: common modu-
latory genes (wzg, wzh, wzd, wze) at the 5′ end of the cps 
locus that are unlikely to alter the polysaccharide structure, 
serotype-specific genes (consisting mainly of different glyco-
syltransferases and acetyltransferases) and sugar synthesis 
genes required for capsule production typically found at the 
3′ end of the cps locus [5, 9, 10]. Capsular gene acquisition 
from other pneumococci as well as other streptococci such 
as S. mitis and loss of gene function may have caused the 
emergence of novel serotypes [11, 12].
Safe, effective conjugate vaccines that target the capsular 
polysaccharide have been developed and administered glob-
ally since 2000; however, these vaccines are limited in their 
serotype valency as they are designed to target only the 10–13 
serotypes most prevalent in invasive pneumococcal disease 
(IPD). Whilst pneumococcal conjugate vaccines (PCVs) have 
had a significant effect on the prevalence of IPD caused by 
vaccine-types (VTs), disease caused by non-vaccine types 
(NVTs) has steadily increased partially offsetting the total 
reduction in disease [13–15]. At the same time, pneumococcal 
carriage rates have remained static due to serotype replace-
ment. Two mechanisms have been suggested for serotype 
replacement: lineage replacement (NVT lineages expand to 
fill the vacant ecological niche caused by the removal of VT 
lineages from the population) and within-lineage NVT expan-
sion (NVT members of a lineage increase in prevalence as VT 
members decline) [16, 17]. Both mechanisms, in particular 
lineage replacement, may potentially lead to an increase in 
previously rare or unobserved serotypes as well as the evolu-
tion of novel hybrid serotypes through recombination with 
other pneumococci or other streptococcal species [8, 18, 19]. 
Therefore, it is important to understand and monitor the 
true level of pneumococcal capsular diversity, especially as 
isolates and genomes from previously understudied regions 
become increasingly available through projects such as the 
Global Pneumococcal Sequencing (GPS) project (https://
www. pneumogen. net/ gps/).
The large number and global distribution of the genomes in 
the GPS dataset provides an unprecedented opportunity to 
attempt to identify novel cps loci using a dataset consisting 
of 18 398 genomes which includes 66 of the ~100 described 
serotypes. The aim of this study was to screen for putatively 
novel cps loci and further characterize any putative novel cps 
loci identified so as to produce a list of candidates for further 
analysis.
mETHoDS
Isolate collection
Isolates in the GPS collection were collected, cultured and 
sequenced as previously described [20]. A total of 18 768 
sequenced genomes were available for inclusion in this study 
(August 2017). Each genome was assigned to a supraregion 
based on the country of isolation (Fig. 1a and Supplementary 
File 2). Serotypes were initially assigned to the isolates on the 
basis of standard experimental methods including Quellung, 
latex agglutination and PCR-based arrays.
Serotypes and lineages
In silico serotypes were assigned to the genomes using 
SeroBA version 1.0.0 [21], a recently described method for 
determining serotypes based on whole genome sequencing 
(WGS). Only serotypes represented by >5 genomes were 
included, resulting in the exclusion of 14 uncommon sero-
types: 7A, 9A, 10C, 10X, 11C, 17A, 25A, 32F, 33A, 33C, 
39X, 41F, 42 and 43 (n=44). In addition, 178 non-typeable 
or non-encapsulated (NT) [22] and 148 un-typeable (a 
serotype prediction was unable to be made) genomes were 
also removed from the dataset. Genomes were predicted 
as un-typeable due to insufficient read coverage over the 
reference sequence (<10×; n=48; read coverage across the 
entire genome was low for these samples), the presence of 
the nspA/pspK NT variant [18, 23] not included in SeroBA’s 
list of references (n=99) and failures due to software errors 
(n=1). Thus, only 49/18 768 (0.003 %) genomes in the initial 
dataset were discarded because no serotype could be inferred 
either due to low mapping coverage (n=48) or software fail-
ures (n=1). This left 18 398 genomes covering 66 serotypes 
and cps variants (Table S1). The variant cps loci 23B1 and 6E 
were included with their related serotypes (23B and 6A or 
6B depending on the nucleotide sequence of the cps locus 
background) in the analyses. Due to the uncertainty over the 
ability of SeroBA to differentiate these serotypes from other 
highly similar serotypes, the recently described serotypes 11E 
and 35D were included in the serotype 11A and 35B datasets, 
respectively.
Impact Statement
The antigenic polysaccharide capsule enclosing the 
cell wall is the primary pneumococcal virulence factor, 
protects against phagocytosis by the human immune 
system and is encoded by the cps locus. Nearly 100 
capsular types or serotypes have been described to date, 
but new serotypes continue to be discovered especially 
in previously understudied regions. We used the largest 
ever pneumococcal genome collection of over 18 000 
genomes to screen for putatively novel cps loci that could 
potentially code for novel serotypes. We identified nine 
putatively novel cps loci in a variety of pneumococcal line-
ages and in a number of different countries across the 
globe. Pneumococcal isolates with each of the putative 
novel cps loci will be sent for biochemical and serological 
characterization to establish whether they encode novel 
polysaccharides. This study provides a major advance in 
our understanding of the potential undiscovered sero-
type diversity in a globally important pathogen whose 
primary vaccine strategy is the targeting of particular 
serotypes. The work will be of broad interest to micro-
biologists, epidemiologists and researchers studying the 
impact of pneumococcal vaccines on the global pneumo-
coccal population.
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Fig. 1. (a) World map showing the global distribution of the samples in 
the study dataset. (b) Bubble plot showing the 66 serotypes included 
in the dataset (the area of each circle is proportional to the number of 
samples).
Recently, 621 pneumococcal lineages (GPSC1–GPSC621) 
were defined based on a collection of 20 027 genomes from 
the GPS dataset and other previously published datasets using 
a Kmer-based clustering tool PopPUNK [24, 25]. These line-
ages were assigned to the genomes included in this study and 
used in place of sequence type (ST) or clonal complex (CC).
mapping and phylogenetics
For each serotype, sequence reads were mapped back to the 
appropriate reference (Table S2) using BWA mem version 
0.7.17 (minimum and maximum insert sizes of 50 and 1000, 
respectively) to create cps locus alignments. SNPs were called 
and annotated using SAMtools version 1.2 mpileup [26] and 
BCFtools version 1.2 as previously described [27] using 
the following criteria: two reads spanning the base in each 
direction with at least 75 % consensus, a minimum base call 
quality of 50 and a minimum root squared mapping quality 
of 30. Alignments containing SNP sites were extracted from 
the resulting alignments using SNP-sites version 2.4.1 [28] 
and maximum-likelihood phylogenies were constructed 
using FastTreeMP version 2.1.9 [29] (nucleotide general 
time-reversible model) and visualized and annotated with 
metadata using iCANDY (https:// github. com/ simonrharris/ 
iCANDY) and Inkscape (http://www. inkscape. org/).
Sequence analysis
Average nucleotide identity (ANI) values were calculated 
for longer sequences (i.e. complete cps loci) using FastANI 
version 1.0 [30] with a fragment length of 1000 bp and a 
minimum number of fragments equal to 50. Nucleotide 
identity (NI) values were calculated using cd-hit version 4.6 
[31] using the alignment criteria of 90 % identity and 90 % 
alignment. blast [32] was used to generate comparisons 
between reference and putative novel cps locus nucleotide 
sequences, and comparison figures were generated using the 
Artemis Comparison Tool (ACT) [33] and edited in Inkscape.
Identification of novel cps loci
The distribution of SNPs and the percentage of the reference 
mapped by sequence reads were assessed for each serotype; 
genomes with cps loci that had a higher number of SNPs 
compared to other genomes predicted to have that serotype, 
as well as a lower percentage of the reference covered by 
sequence reads, were considered to be putative novel cps loci 
and investigated further (Fig. 2).
RESuLTS
In total, 18 398 genomes from 54 countries and 15 supra-
regions were included in this study (Fig. 1a). The suprar-
egions most represented in the dataset were Southern Africa 
(n=6768), West Africa (n=3393), North America (n=1901), 
East Asia (n=1560) and the Middle East (n=1365); these 
regions included the key pre- and post-vaccine collections 
from South Africa, The Gambia, USA, Malawi and Israel. 
Approximately 60 % of the isolates were from invasive disease 
whilst the rest were from carriage or unknown sources.
A total of 66 serotypes and cps variants were included in this 
study (Fig. 1b). Of the genomes included in the analyses, 
44.2 % (n=8136) had serotypes targeted by the 10-valent 
Pneumococcal Conjugate Vaccine (PCV10) and 60.8 % 
(n=11 188) serotypes targeted by the 13-valent PCV13. The 
serotypes not targeted by either of the currently available 
PCVs with the most representation were serotypes 15B/15C 
(n=801), 12F (n=546), 16F (n=463) and 11A/11E (n=375). 
The screen of 18 398 genomes revealed that 476 (2.6 %) had 
putative novel cps loci, of which there were nine examples 
(Table 1, Fig. 2 and Table S3).
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Fig. 2. Identification of putative novel cps loci; plots of total SNPs against the percentage of the serotype reference covered by sequence 
reads are shown for nine serotypes with putative novel cps loci (highlighted in red).
9X
Analyses of 75 serotype 9L genomes revealed nine with a 
distinct SNP profile (mean 171.1 SNPs versus mean 8.51 
SNPs; Fig. 2) hereafter referred to as serotype 9X (Fig. 3a). 
The nine isolates were collected in Africa (Ethiopia, Mozam-
bique, South Africa, Ghana and Nigeria), belonged to six 
different lineages (GPSC17, GPSC26, GPSC455, GPSC649, 
GPSC684 and GPSC772) and were observed in both 
invasive disease and carriage. A closer examination of the 
blast comparison of the serotype 9X cps locus compared 
to serotypes 9L and 9N revealed that whilst the majority of 
the cps locus closely resembled that of serotype 9L (ANI= 
97.4 %), divergent alleles (<96 % NI) were observed in the wzh 
(90.85 % NI), wze (95.91 % NI), wzy (94.65 % NI) and wcjB 
(95.86 % NI) genes. Additionally, wcjE, which is frameshifted 
in both serotypes 9L and 9N, was replaced by a transposon 
in the serotype 9X cps locus (Fig. 3b).
11X
Examination of the serotype 11A/11E genomes revealed that 
44/375 had a divergent cps locus (11X) with much lower 
reference mapping scores (mean 58.09 % versus mean 
92.06 %; Fig. 2) and a higher number of SNP sites (mean 
281.39 versus mean 116.79) when compared to the rest of 
the serotype 11A/11E genomes (Fig. 4a). Comparison of the 
11X nucleotide sequence with the serotype 11A reference 
(ANI=93.9 %) showed that 11X contains divergent alleles 
for wcwC (acetyltransferase; 90.31 % NI) and wcrL (glyco-
syltransferase; 85.48 % NI).
16X
Two distinct clades were observed in the serotype 16F 
phylogeny with clear separation between reference-like 
sequences (mean 64.1 SNPs; n=125) and a clade with a 
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Table 1. Summary of putative novel cps loci identified in this study
Putative novel cps loci (in alphanumerical order by related serotype).
Putative cps locus Genomes (n) GPSC lineages (n) Supraregions (n) Countries (n) Carriage (n) Disease (n) Collection 
dates
9X 9 6 3 5 5 4 2007–2014
11X 44 5 3 4 43 1 2000–2017
16X 338 11 2 6 251 72 2003–2016
18X1 1 1 1 1 1 0 2014
18X2 7 4 3 5 2 5 2006–2016
18X3 16 4 5 7 4 12 1999–2013
29X 29 5 2 5 7 20 2000–2015
33X 30 3 7 10 10 20 2003–2015
36X 2 2 2 2 2 0 2009
divergent serotype 16X cps locus (mean 240.9 SNPs; n=338; 
ANI compared to 16F: 97.4 %; Fig. 5a). All of the serogroup 
16X pneumococci were collected in Southern and West Africa 
(The Gambia, Malawi, South Africa, Ghana and Cameroon) 
and were from 11 GPSC lineages. The majority (74.3 %) of the 
isolates were from carriage while the remaining isolates were 
from invasive disease or unknown sources. Divergent alleles 
were present in the wzh (82.79 % NI), wzd (88.17 % NI), wze 
(94.15 % NI) and wchF (95.40 % NI) genes.
18X1 and 18X2
A single genome typed as serotype 18A had a putative novel 
cps locus (ANI=95.85 %; 261 SNPs versus mean 33.9 SNPs; 
Fig. 2). This putative sequence, 18X1, was collected in India 
in 2014 from a nasopharyngeal swab and was from GPSC71. 
Seven serotype 18C genomes also had a putative novel cps 
locus, 18X2 (ANI=96.83 %; mean 315.9 SNPs versus mean 
55.0 SNPs; Fig. 2). Most (5/7; 71.4 %) of the serotype 18X2 
genomes were collected in South Asia (India, Pakistan and 
Bangladesh) and belonged to four GPSC lineages (GPSC85, 
GPSC142, GPSC454 and GPSC752). A comparison of the 
18X1 and 18X2 sequences revealed that they share a high level 
of similarity (ANI=99.10 %; Fig. 6) although 18X1 appears 
to have recombined with serotype 21 at the 3′ end (Fig. S1). 
Examination of the 18X1 and 18X2 cps locus revealed that 
there were divergent alleles for wchF (94.54 % NI), wciU 
(95.60 % NI), wciW (81.90 % NI) and rmlA (91.03 % NI). 
Additionally, glf (frameshifted in 18X2) was present in 18X1 
and 18X2 but not present in either serotypes 18A or 18C.
18X3
The majority (16/19; 84.2 %) of the genomes typed as sero-
type 18F had a putative novel cps locus (ANI 96.13 %) with 
a distinct SNP profile (mean 203.34 SNPs versus mean 39.33 
SNPs; Figs 2 and 7a). These serotype 18X3 genomes were 
primarily collected in Africa (Ethiopia, Malawi, South Africa 
and The Gambia; n=13) although single isolates were collected 
in Bangladesh, France and Pakistan. The majority (12/16; 
75.0 %) were from invasive disease and a single lineage, 
GPSC142 (10/16; 62.5 %). Divergent alleles for wzh  
(93.17 % NI), wzd (76.91 % NI), wze (83.92 % NI), wchF 
(94.71 % NI), wcxM (94.76 % NI) and rmlA (92.99 % NI) 
were present in the 18X3 cps locus, and glf was replaced 
with a transposon (Fig. 6b). Comparison of the divergent 
wzh, wzd and wze genes to other serotype sequences 
revealed that there was a high level of similarity (97.40 % 
NI) between these alleles and those of serotype 45.
29X
In total, 29/45 genomes typed by SeroBA as serotype 29 had a 
distinct SNP profile (mean 139.51 SNPs; Fig. 2) compared to 
the reference-like serotype 29 cps loci (mean 28.63 SNPs). All 
of these serotype 29X pneumococci were collected in Africa 
(Malawi, Mozambique. South Africa, Benin and Ghana), 
primarily from invasive disease (20/29; 69.0 %) and comprised 
several GPSC lineages (Fig. 8a). The ANI of the 29X cps locus 
was 95.8 % compared to the serotype 29 reference with highly 
divergent alleles observed for wzh (83.61 % NI), wzd (<70 % 
NI), wze (77.92 % NI) and wzx (79.66 % NI). Comparison 
of the wzh, wzd and wze nucleotide sequences to other sero-
types identified the equivalent genes in serotype 12F as being 
highly similar (98.14 % NI). Additionally, the serotype 29X 
cps locus has an extra frameshifted wciG (acetyltransferase) 
located between wzx and glf (Fig. 8b), which is very similar 
(99.40 % NI) to wciG from serotypes 32F and 35F where the 
gene is functional.
33X
In total, 115 serotype 33F pneumococci were identified 
in the dataset and, of these, 30 had a distinct SNP profile 
(mean 143.27 SNPs versus mean 4.84 SNPs; ANI=96.50 %; 
Figs 2 and 9a). These serotype 33X isolates were collected 
in ten different countries in seven different supraregions, 
suggesting a global distribution for this putative novel cps 
locus. The majority were collected from cases of invasive 
disease (20/30; 66.7 %) and the genetic lineage of the isolates 
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Fig. 3. (a) Phylogeny and SNP map of serotype 9L. (b) Comparison of the putative serotype 9X sequence and the serotype 9L and 9N 
reference sequences.
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Fig. 4. (a) Phylogeny and SNP map of serotype 11A. (b) Comparison of the putative serotype 11X sequence and the serotype 11A and 11F 
reference sequences. (c) Phylogeny containing the serogroup 11 references, serotype 11X and PMP1343.
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Fig. 5. (a) Phylogeny and SNP map of serotype 16F. (b) Comparison of the putative serotype 16X sequence and the serotype 16F reference 
sequence.
was conserved with 23/30 (76.7 %) coming from GPSC3 or 
GPSC236 (Fig. 9b). The 33X cps locus was primarily 33F-like 
but divergent alleles were present for wciG (89.46 % NI) and 
glf (89.46 % NI) and the frameshifted wcjE, which differenti-
ates serotypes 33A and 33F, was replaced by a frameshifted 
wcyO, which was highly similar to the non-frameshifted 33C 
wcyO (99.27 % NI).
36X
A small number of genomes in the GPS dataset (n=6) were 
typed as serotype 36, and of these, two had a divergent 
SNP profile (mean 171.50 SNPs versus mean 6.75 SNPs; 
ANI=96.77 %; Figs 2 and 10a). The serotype 36X pneumo-
cocci were collected in Ethiopia and Nepal and were both 
from carriage (Fig.  10a). The serotype 36X cps locus has 
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Fig. 6. (a) Phylogeny and SNP map of serotype 18A. (b) Phylogeny and SNP map of serotype 18C. (c) Comparison of the putative serotype 
18X sequences and the serotype 18A and 18C reference sequences.
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Fig. 7. (a) Phylogeny and SNP map of serotype 18F. (b) Comparison of the putative serotype 18Xii sequence and the serotype 18F 
reference sequence.
divergent alleles for the glycosyltransferases wchO (92.12 % 
NI) and wcjA (85.36 % NI) when compared to the reference 
(Fig. 10b). A GenBank query revealed that the closest matches 
for wchO (98.06 % NI) and wcjA (95.67 % NI) were from other 
streptococcal species such as S. mitis and S. pseudopneumo-
niae, suggesting that the serotype 36X cps locus has recently 
undergone a recombination event.
DISCuSSIon
The aim of this study was to screen the GPS dataset and 
identify putative novel cps loci that may encode novel 
serotypes. The very large number of genomes and broad 
geographical coverage of the dataset enabled the first detailed 
sequence-based analysis of the majority of previously identi-
fied serotypes. Other studies have analysed large numbers 
of pneumococcal genomes (n =~5000) but, apart from the 
more common serogroups such as 6 and 19, the number of 
genomes analysed for many of the serotypes was relatively 
small [8, 19]. This study revealed that despite the large number 
of genomes (and serotypes) included, the number of putative 
novel cps loci was very small: of the 18 398 genomes included, 
only 476 (2.6 %) had putative novel cps loci comprising nine 
different examples. This was perhaps unexpected given the 
number and diversity of genomes included; to date nearly 
100 serotypes have been identified, with several discovered 
in the past decade, suggesting that the total number of pneu-
mococcal serotypes was much higher. In fact, the results 
of this study suggest that we are now close to discovering 
the total amount of extant global pneumococcal serotype 
diversity. However, 30 serotypes were not included in this 
study due to them either not being present in the GPS dataset 
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Fig. 8. (a) Phylogeny and SNP map of serotype 29. (b) Comparison of the putative serotype 29X sequence and the serotype 29 reference 
sequence.
(n=16) or else present in fewer than five genomes (n=14). The 
pubMLST S. pneumoniae isolates database (https:// pubmlst. 
org/ spneumoniae/) which contains >40 000 records, was 
queried for the prevalence of the excluded serotypes: only 
serotype 24F (n=214) was found in more than 50 records, 
suggesting that the missing serotypes could be considered 
uncommon. However, these may also be a source of novel 
cps loci so future work should include collecting as many 
12
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Fig. 9. (a) Phylogeny and SNP map of serotype 33F. (b) Comparison of the putative serotype 33X sequence and the serotype 33F reference 
sequence.
examples of each rare serotype to determine the diversity of 
their cps loci.
Despite the comparatively small number of genomes with 
putative novel cps loci, there was a surprising amount of 
diversity amongst the genomes with these cps loci, especially 
with respect to geography, genomic lineage and their 
prevalence in both carriage and disease. Pneumococci with 
putative novel cps loci were found in nine of the 15 supra-
regions assigned in this study, with nearly every continent 
represented. Seven of the nine putative novel cps loci were 
13
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Fig. 10. (a) Phylogeny and SNP map of serotype 36. (b) Comparison of the putative serotype 36X sequence and the serotype 36 reference 
sequence.
present in both Southern and West Africa, suggesting that 
future studies including African isolates may reveal addi-
tional novel cps loci. The most represented putative novel cps 
locus in the dataset was 16X (338/446 genomes), probably 
due to the high prevalence of serotype 16F (the majority of 
which had the 16X cps locus) in South Africa and Gambia, 
which both contributed large numbers of isolates to the GPS 
project. The most globally distributed novel cps locus was 
33X as it was found in seven supraregions comprising ten 
different countries. There were 40 different GPSC lineages, 
comprising a large amount of the diversity in the genomic 
background of the pneumococci, with putative novel cps 
loci and, on average, each putative novel cps locus was found 
in four to five GPSC lineages. With the exception of sero-
types 18X1 and 36X, which were only present in one and 
two genomes respectively, all of the putative novel cps loci 
were found in both carriage and IPD. Serotypes 18X2 (5/7; 
71.4 %), 18X3 (12/16; 75 %), 29X (20/29; 70 %) and 33X 
(20/30; 67 %) were more commonly found in IPD isolates 
whilst serotype 11X was almost exclusively found in carriage 
(43/44; 97.7 %). Gladstone et al. (Gladstone accepted by 
EbioMed) calculated invasiveness using odds ratios for 
some of the serotypes associated with putative novel cps 
loci: serotype 11A was significantly associated with carriage 
whilst serotypes 18C and 33F were significantly associated 
with disease. The carriage/disease distributions of the 
putative novel cps loci 18X2 and 33X matched those of the 
related serotypes whilst 11X, being more commonly found 
in disease, did not match the distribution of serotype 11A.
The introduction of PCVs has had a dramatic effect on the 
global pneumococcal population with VTs decreasing in 
prevalence in both invasive disease and carriage. At the same 
time disease caused by NVTs has increased along with the 
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related stable carriage rates. Due to this ecological perturba-
tion, it is possible that previously rare or unknown serotypes 
may increase in circulation allowing them to be more likely 
to be detected. The evidence in this study for this is relatively 
limited given the small numbers and wide geographical 
distribution of most of the genomes with putative novel cps 
loci. However, 182/338 genomes with the 16X cps locus from 
the same lineage, GPSC33, and collected in South Africa 
increased from 42 isolates pre-vaccine to 99 post-PCV, 
although this increase in prevalence may be due to a clonal 
expansion rather than because of the novel cps locus. All of 
the above observations highlight the necessity for continued 
global WGS surveillance of important pathogens such as 
pneumococcus.
A number of methods were used to serotype the isolates 
collected as part of the GPS project, with Quellung or a 
combination of Quellung and PCR or Quellung and micro-
array, accounting for the majority (10 728/12 369; 86.7 %) of 
the phenotypic serotypes provided at the time of sequencing. 
A significant number of the isolates included in this study 
lacked phenotypic data for the serotype (6013/18 382; 32.7 %).
All of the serotype assignment for the genomes included in 
this study was performed by WGS using SeroBA and showed 
good concordance with the phenotypic methods such as 
Quellung or Latex agglutination (Table S1). Using the results 
of the WGS-based serotyping also allowed genomes lacking 
phenotypic classification, which otherwise would have been 
excluded, to be included in the analyses. This highlighted that 
it is now much simpler and faster to serotype pneumococci 
using the genome sequence and only perform further pheno-
typic classification in the event of one of the WGS-based tools 
failing due to a misassembly or else a cps locus distinct from 
the set of reference genomes.
Various different mechanisms are responsible for differences 
between the polysaccharides produced by the pneumococcal 
cps locus and many of these were identified in this study. 
Previous studies have shown that small changes to cps locus 
genes, such as single amino acid changes as in serotypes 6A 
and 6B, may lead to differences in the polysaccharide struc-
ture whilst sequence divergence of 5 %, as in the case of the cps 
locus variant 6E (6Bii) and serotype 6B, or the 30 % divergence 
in homology between serotype 23B and the 23B1 variant, may 
not lead to a change in the structure of the polysaccharide 
capsule [34, 35]. In a number of serotypes, such as 9A, 22A 
and 33F, the differences between the polysaccharide capsules 
produced by highly similar cps loci (e.g. 9V, 22F and 33A) are 
due to frameshifts in genes at the 3′ end of the cps locus such 
as gct and wcjE. This is due to mutations in these genes not 
affecting the genes at the 5′ end of the cps locus, which allows 
disruptive mutations which would be lethal if they occurred 
elsewhere in the operon [10, 36]. Different polysaccharide 
structures may also occur when these genes are replaced 
by transposons such as in serotype 16F. Examples of both 
of these mechanisms were observed in this study. Serotype 
11X, like 11A, has an intact gct which correlates with the 
presence of gro-IP in the polysaccharide (gct is frameshifted 
and thus inactive in serotype 11F) [12]. The presence of the 
functional glf in 18X1 suggests that galactofuranase may 
be present in the polysaccharide and absent in 18X2. The 
serotype 33C-like frameshifted wcyO in serotype 33X has 
been shown to mediate the same capsular modification as 
the serotype 33F wcjE [37, 38]. Two examples of wcjE or glf 
being replaced by transposons were observed in serotypes 9X 
and 18X3, respectively. The replacement of glf by a transposon 
in the 18X3 cps locus suggests that galactofuranase may be 
absent in the 18X3 polysaccharide capsule.
Amino acid changes to acetyltransferases and glycosyl trans-
ferases as well as additional copies of these genes may change 
the acetylation profile, repeat patterns and sugar constitu-
tion of the polysaccharide capsule. Examples of changes to 
acetyltransferases were found in many of the putative novel 
cps loci. For instance, amino acid changes in wcwC, similar 
to those found in serotype 11X, have been shown to lead to 
differences in acetylation whilst wcrL encodes a glycosyl-
transferase responsible for different sugars in serotypes 11F 
(GlcpNAc) and 11A (Glcp) [39]. The complete structure of 
the serotype 16F polysaccharide is currently unknown but 
amino acid changes in the glycosyltransferase wchF of sero-
type 16X may change the constituents of the polysaccharide 
repeat units [11]. Due to recombination between the 18X2 
and serotype 21 cps loci, the 18X1 cps locus also possesses an 
additional acetyltransferase, wcyO, which may lead to differ-
ences in acetylation in the polysaccharide whilst the variant 
acetyltransferase, wcxM of serotype 18X3, may also lead to 
differences in acetylation when compared to serotype 18F. 
The unique glycosyltransferase wciW found in serotypes 18X1 
and 18X2, along with amino acid changes in wchF, suggests a 
different pattern of polysaccharide repeat units. The 18X1 and 
18X2 wciU allele is more similar to the 18C version; this gene 
is responsible for the addition of Glcp to the polysaccharide 
capsule in serotypes 18B, 18C and 18F and GlcpNAc in 18A. 
The serotype 29X cps locus has an additional frameshifted 
wciG (acetyltransferase), located between wzx and glf, which 
is very similar (99.40 % NI) to wciG from serotypes 32F and 
35F where the gene is functional. The divergent alleles for 
the glycosyltransferases wchO and wcjA in serotype 36X 
may also lead to changes in the patterns of repeats in the 
polysaccharide.
Other studies have recently identified new serotypes [7, 8], 
particularly amongst pneumococci isolated in particular 
regions such as South East Asia, which is currently under-
represented in this collection. The serotype 11X cps locus 
has been previously identified [19, 40] and has been 
shown to possess a predominately serotype 11F cps locus 
while phenotypically serotyping, using Quellung and latex 
agglutination, as serotype 11A. An example of this novel 
serotype or serotype variant (PMP1343) was made publicly 
available and was included in a phylogenetic tree along with 
11X and the other members of serogroup 11 (Fig. 4c). The 
close proximity of PMP1343 and 11X confirmed that these 
are likely to be the same cps locus type as well as showing 
that the cps locus, whilst closely related to serotype 11F, is 
unique (Fig. 4c). In total, 42/44 serotype 11X pneumococci 
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were collected in Cambodia and Hong Kong, suggesting 
a primarily Asian or Pacific distribution, in line with the 
previous findings that pneumococci with this cps locus have 
previously been collected in Fiji, Thailand, Mongolia and 
Laos [19, 40]. The serotype 33X cps locus has recently been 
found (labelled as serotype variant 33F-1) in pneumococci 
isolated from healthy children and children with pneumonia 
in Fiji and Mongolia, respectively [38]. These studies along 
with the analysis conducted in this paper show that novel 
serotypes will continue to be discovered as more pneumo-
cocci from previously understudied regions are sequenced.
The methodology used in this study was designed to identify 
highly divergent cps loci with different alleles of the same 
gene as well as additional genes as were identified in serotype 
36X. The analyses were not designed to be sensitive to very 
fine changes in the cps loci such as non-synonymous muta-
tions leading to amino acid changes. It is likely that there 
would be additional diversity in the form of putative novel 
cps loci, when considering small-scale changes such as non-
synonymous mutations, that has not been detected in this 
analysis. One of the aims of this study was to screen a large 
number of genomes using a simple, robust method that would 
quickly identify divergent cps loci before focusing on genomes 
with loci of interest. Given the scale of this undertaking and 
the large number of putative novel cps loci identified that will 
be studied further, it was decided that a finer scale analysis 
would form part of a subsequent study that will make use of 
the outputs generated as part of this study. This analysis will 
be conducted alongside the studies detailing the serological 
and biochemical characterisation of the putative novel cps loci 
identified in this study.
Examples of pneumococci with each putative novel cps 
locus identified in this study will undergo further analyses 
including the biochemical elucidation of their polysaccharide 
structure, confirming that capsules are being produced, i.e. 
proving that these putative novel cps loci are not just defective 
variants of known cps loci, and assessing how these capsules 
react serologically to known sera using Quellung. Whilst 
techniques such as GLC and NMR have revolutionized the 
study of polysaccharide structures, difficulties still remain 
[10]. In particular, these techniques rely on pure capsular 
polysaccharides, which depending on the serotype may be 
difficult to purify due to the inclusion of the covalently linked 
cell-wall polysaccharide. Some of the putative novel cps loci 
identified are similar to cps loci for which the polysaccharide 
structure is yet to be discerned (serotypes 16F, 29 and 36) so 
structures for these serotypes will also need to be determined 
at the same time to establish whether the novel cps loci are 
indeed undescribed.
This study identified nine putative novel cps loci in a large, 
global dataset although the number of genomes with these cps 
loci was comparatively small, suggesting that the majority of 
pneumococcal serotypes have now been identified. However, 
given that many of these genomes were from regions such 
as Africa and South-East Asia where pneumococcal genome 
sequencing has to date been infrequent, further monitoring 
and surveillance of pneumococcal cps loci coming from these 
regions is required.
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